Table 4.

Comparison Between DM vs Non-DM Eyes

	DM Group (n = 30)	Non-DM Group (n = 35)	P Value
CC FD% (T1)	54.61 [51.18–59.79]	51.51 [41.14–58.07]	0.037
CC FD% (T2)	54.04 [49.71–60.12]	47.09 [40.15–54.41]	0.002
CC FDa (T1)	108.28 [78.75–176.76]	78.05 [41.59–119.81]	0.005
CC FDa (T2)	92.64 [67.58–150.52]	67.92 [35.41–87.27]	0.001
CC FDn (T1)	261.0 [172.9–492]	536.0 [319.8–890.8]	0.068
CC FDn (T2)	288.8 [199.0–419.7]	738.0 [382.0–1000]	0.056

Data are presented as median [IQR].

FDa, FD average area; FDn, flow deficits number; T1, before loading anti-VEGF therapy; T2, after loading anti-VEGF therapy.

The Friedman nonparametric test was performed to obtain P values.